Gene Query: INPP5J

Dataset Description Geneva Score
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 42.15
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 35.96
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 21.92
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 20.66
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 13.39
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 13.39
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 10.44
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 10.02
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 9.86
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 9.71
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 9.57
Gene expression profiling of papillary thyroid cancer from central and invasive regions 9.27
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 8.75
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 7.89
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 7.82
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 7.63
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 7.25
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 7.01
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 6.74
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 6.22
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 6.14
A prostate cancer chromatin interaction map 6.01
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 5.84
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 5.84
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 5.77
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 5.17
AR-independent prostate cancer is sustained through FGF signaling 4.76
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 4.71
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 4.7
Tracking of dCas9-methyltransferase footprints 4.67
The landscape of alternative splicing in aggressive prostate cancers 4.54
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 4.49
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 4.42
A practical evaluation of alignment algorithms for RNA variant calling analysis 4.4
Paxillin regulates genomic networks in prostate cancer [C4-2] 4.22
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 3.97
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 3.93
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 3.71
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 3.7
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 3.7
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 3.66
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 3.63
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 3.6
SRSF2 mutations impair hematopoiesis and alter exon recognition 3.59
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 3.48
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 3.48
Transcriptional profiling of LS1034 cells treated with tepoxalin 3.42
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 3.36
Gene expression profile in breast cancer cell lines using RNA sequencing 3.35
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 3.26
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 3.26
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 3.26
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 3.24
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 3.21
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 3.2
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 3.2
Interaction between mitoNEET and NAF-1 in cancer cells 3.18
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 3.15
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 3.0
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 2.91
Genome-wide identification of cancer-specific alternative splicing in circRNA 2.91
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 2.89
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 2.87
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 2.87
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 2.84
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 2.81
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 2.81
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 2.8
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 2.76
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 2.73
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 2.62
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 2.6
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 2.59
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 2.57
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 2.57
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 2.56
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 2.56
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 2.51
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 2.5
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 2.5
Androgen Receptor-regulated genes in prostate cancer cells 2.49
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 2.49
Differentiation enhances Zika virus infection in neuronal brain cells 2.48
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 2.47
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 2.47
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 2.43
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 2.43
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 2.42
Patient-derived luminal breast cancer xenografts with progestins 2.42
RNA-seq analyses of human prostate cancer cells 2.4
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 2.37
The MEF2B Regulatory Network - RNA-seq data 2.37
The MEF2B Regulatory Network 2.37
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 2.36
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 2.25
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 2.19
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 2.18
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 2.18
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 2.16
BET bromodomain inhibition 2.14
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 2.14
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 2.13
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 2.13
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 2.1
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 2.1
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 2.1
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 2.1
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 2.08
Transcriptome analysis of SKI knock-out in HL60 cells 2.05
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 2.05
Gene expression changes after LOC550643 silencing 2.05
EP400 is required for Max and MCPyV mediated gene activation 2.04
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 2.03
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 2.01
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 2.01
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 1.99
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 1.99
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 1.95
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 1.92
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 1.92
Identification of HOXB13 target genes responsive to BET inhibitors 1.91
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 1.88
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 1.86
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 1.86
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 1.84
A transcriptome-wide divergence in protein translation scales with LIN28B expression 1.83
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 1.79
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 1.78
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 1.78
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 1.78
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 1.78
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 1.77
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 1.77
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.77
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 1.75
NR2F2 study 1.75
The effect of PPARG inhibition on human angiomyolipoma cells 1.73
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 1.7
Fusion discovery in breast cancer cell line 1.7
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 1.67
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 1.67
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 1.67
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 1.66
Effect of CHKA knockdown on C4-2 cell transcriptome 1.63
Gene expression profile difference among renal location in a stone former 1.61
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 1.6
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 1.58
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 1.58
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 1.58
MeRIP-seq for heat shock in B-cell lymphoma cells 1.58
Total RNA sequencing of APC mutant and wt colonic organoids 1.57
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 1.54
Gene expression analysis of the impact of TDP-43 knockout in human cells. 1.54
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 1.5
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 1.5
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 1.48
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 1.48
Controlling for gene expression changes in transcription factor protein networks. 1.48
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 1.42
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 1.41
Gene expression analysis of breast cancer cell-lines 1.41
Gene expression and genome-wide location analysis of breast cancer cell-lines 1.41
MOF acetyl transferase regulates transcription and respiration in mitochondria 1.39
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 1.35
Repurposing of promoters and enhancers during mammalian evolution 1.35
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 1.32
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 1.31
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 1.31
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 1.3
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 1.3
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 1.27
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 1.27
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 1.26
Transcriptional changes in lymphoma cells induced by LSD1 depletion 1.26
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 1.26
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 1.26
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 1.24
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 1.22
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 1.21
Lysine benzoylation is a novel histone mark 1.2
Lysine benzoylation is a novel histone mark [RNA-seq] 1.2
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 1.19
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 1.19
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 1.19
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 1.18
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 1.18
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 1.17
Tyrosine Kinase Inhibitor Cardiotoxicity 1.17
The transcriptome effect of overexpressing EZH2 in MCF7 1.17
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 1.17
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 1.17
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 1.15
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 1.15
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 1.14
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 1.14
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 1.14
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 1.14
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 1.1
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 1.1
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 1.09
AUF-1 affected genes in human skin cells 1.08
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 1.06
Transcriptome-wide identification of CELF2 functional targets in T cells 1.06
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 1.01
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 1.0
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 1.0
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 1.0
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 1.0
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 0.99
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 0.99
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 0.98
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 0.98
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 0.98
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 0.98
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 0.97
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 0.97
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 0.97
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 0.97
RNA-seq analysis of breast cancer 0.97
RNA-seq analysis and shRNA screen of breast cancer 0.97
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 0.96
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 0.95
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 0.94
mRNA-sequencing of breast cancer subtypes and normal tissue 0.93
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 0.92
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 0.91
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 0.9
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 0.9
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 0.89
HNRNPL and its RNA Targets in Prostate Cancer 0.89
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 0.89
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 0.88
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 0.88
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 0.88
ENCODE Cold Spring Harbor Labs Long RNA-seq 0.88
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 0.87
Functional role of SLIT2 and ROBO1 in trophoblasts 0.86
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 0.85
T47D RNA-seq and ChrRNA-seq data 0.85
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 0.85
Tracing Enhancer Networks using Epigenetic Traits (TENET) 0.85
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 0.84
HNRNPM-regulated splicing dependencies in prostate cancer 0.84
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 0.83
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 0.83
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 0.82
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.81
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 0.8
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 0.79
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.78
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.77
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 0.77
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 0.77
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 0.77
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 0.77
Genome wide expression change by RNF168 knocking down in NEC cells 0.76
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 0.75
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 0.74
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 0.73
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 0.73
Effect of PBK knockdown on C4-2 cell transcriptome 0.72
Overexpression of NFIB and YBX1 in MCF-7 cells 0.72
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 0.71
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 0.7
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 0.7
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.7
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 0.7
MYCL and EP400 are required for Max and MCPyV mediated gene activation 0.69
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 0.69
snRNAs as regulators of alternative splicing 0.68
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 0.68
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 0.68
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 0.68
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 0.68
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 0.67
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 0.67
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 0.66
mRNA sequencing analysis of cultured human primary airway epithelial cells upon exposure to PMN exosomes 0.66
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 0.66
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.66
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 0.65
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 0.65
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 0.65
4sU-seq of HFF exposed to salt and heat stress 0.65
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 0.64
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 0.64
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 0.63
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 0.63
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 0.63
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 0.63
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 0.62
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 0.62
Alteration of the microRNA network during the progression of Alzheimer’s disease 0.61
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 0.61
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 0.61
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 0.6
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 0.6
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 0.6
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 0.6
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 0.59
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 0.58
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 0.58
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 0.58
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 0.58
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 0.58
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 0.58
DART-seq: an antibody-free method for global m6A detection 0.58
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 0.57
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 0.57
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 0.57
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 0.57
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 0.57
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 0.57
CHCHD10 gene KO effect in iPSC drived motor neurons 0.56
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 0.56
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 0.56
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 0.55
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 0.55
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 0.52
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 0.52
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 0.52
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 0.51
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 0.5
Global analysis of alternative splicing regulated by RBM10 0.5
NHLRC1 re-expression in cancer cells 0.5
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 0.5
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 0.49
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 0.49
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 0.49
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 0.49
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 0.49
Energy Metabolism during Anchorage-Independence 0.49
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.49
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 0.48
A map of gene expression in neutrophil-like cell lines 0.48
Characterization of parental and rociletinib-resistant derived H1975 cell lines 0.48
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 0.48
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 0.48
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 0.47
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 0.47
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 0.47
iPSC derived motor neuron cultures from C9ORF72 carriers 0.46
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 0.45
U2AF1 mutations alter splice site recognition in hematological malignancies 0.43
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 0.42
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 0.42
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 0.42
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 0.41
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 0.41
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 0.41
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 0.41
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 0.41
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 0.4
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 0.4
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 0.4
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 0.4
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 0.4
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.39
mRNA recovered upon RNF219 IP. [RNA-IP] 0.39
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 0.39
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 0.39
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 0.38
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 0.38
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 0.37
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 0.37
Modulation of nonsense-mediated decay by rapamycin 0.37
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 0.37
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 0.36
ADAR1-editing of cellular and measles virus-derived duplex RNA 0.36
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 0.35
RNA Sequencing of Human iPS derived Cardiomyocytes 0.35
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.35
RNA-seq in transgenic cells 0.35
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.35
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.35
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 0.34
Epigenomic conservation of transposable element silencing 0.34
Epigenomic conservation of transposable element silencing [RNA-seq] 0.34
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.33
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 0.33
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.33
KLF6-dependent transcription in renal cancer cells 0.33
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.33
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.33
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 0.32
RNA seq with AML (NB4) cells upon FTO inhibition 0.32
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 0.31
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 0.31
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.3
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 0.29
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.29
A novel target of EZH1/2 for treatment of mantle cell lymphoma 0.29
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 0.29
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 0.28
Identification of global XBP1s target gene expression in human prostate cancer cells 0.28
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.28
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.28
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 0.28
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 0.28
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 0.28
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 0.27
Functional Haploid Human Oocytes Generated from Polar Body Genomes 0.27
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 0.27
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 0.27
Enhancer activation during EGF response 0.27
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 0.27
Gene expression of collecting duct carcinoma of the kidney 0.27
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 0.26
Preclinical model of obesity and ER-positive breast cancer 0.26
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 0.26
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 0.25
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.23
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 0.23
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.23
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 0.23
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.23
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 0.22
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 0.22
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.22
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 0.22
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.21
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 0.21
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 0.21
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 0.21
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.19
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 0.19
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 0.19
RNAseq of Breast cancer PDX samples 0.19
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 0.18
Function and hormonal regulation of GATA3 in human first trimester placentation 0.17
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 0.17
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.17
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.17
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 0.17
HEK293 Heat-shock experiment 0.16
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 0.16
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.16
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 0.16
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 0.15
CHCHD2 gene KO effect in iPSC drived motor neurons 0.15
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 0.15
Co-regulation of splicing by Rbfox1 and hnRNP M 0.15
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 0.15
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 0.15
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 0.14
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.14
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 0.14
Global epigenomic reconfiguration during mammalian brain development 0.14
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 0.14
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 0.13
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 0.13
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 0.13
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 0.12
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 0.12
CDK4/6 inhibitor resistance in prostate cancer 0.12
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 0.12
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 0.12
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 0.12
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 0.11
Gene expression analysis of human adenomas. 0.11
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.11
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.1
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.1
Next generation sequencing of small RNAs isolated from exosomes in human semen 0.1
RNA-sequencing 0.08
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 0.08
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.08
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.08
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.08
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.08
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 0.08
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 0.07
Transposon-based construction of strand-specific RNA-seq libraries 0.07
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.06
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.05
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 0.05
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 0.05
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 0.05
RNAseq analysis of ESRP regulated splicing events in prostate cancer 0.05
LIN28A modulates splicing and gene expression programs in breast cancer cells 0.05
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 0.05
Transcriptome-wide modulation of splicing by the exon junction complex 0.04
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 0.04
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 0.04
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 0.04
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 0.04
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.03
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 0.03
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 0.03
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 0.03
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 0.03
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.02
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 0.02
RNAseq analysis of ruxolitinib treated breast cancers 0.02
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.02
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.02
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.01
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.01
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 0.01
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation